Arvaya Healthcare
114.55
+2.20(+1.96%)
Market Cap₹550.06 Cr
PE Ratio5.97
Company Performance:
1D+1.96%
1M-0.14%
6M+107.41%
1Y+351.87%
5Y+418.33%
View Company Insightsright
More news about Arvaya Healthcare
17Jul 26
Arvaya Healthcare corrects shareholding data in postal ballot notice
Arvaya Healthcare issued a corrigendum to its postal ballot notice, correcting Mr. B. K. Anilkumar's post-issue shareholding to 4.45% and adding a resolution for enhanced lock-in periods on shares allotted to 14 non-promoters. Shareholders can modify votes until August 13, 2026.
 no imag found
08Jul 26
Bijoy Hans Ltd changes name to Arvaya Healthcare Ltd
Bijoy Hans Ltd will officially change its name to Arvaya Healthcare Limited on July 13, 2026, with BSE Limited recording the new name and Scrip ID ARVAYA. The exchange notice confirms the update to the company's abbreviated name on the BOLT Plus System. This action follows a disclosure made in May 2026 regarding the corporate rebranding.
 no imag found
04Jul 26
Bijoy Hans appoints Anilkumar as Executive Director for three years
Bijoy Hans Ltd has appointed Bidari Kotresh Anilkumar as Executive Director for a three-year term effective July 4, 2026, pending shareholder approval. Anilkumar, currently the CEO of SeCURE Hospitals, brings over 12 years of healthcare leadership experience.
 no imag found
26Sept 25
Bijoy Hans Limited to Delist from Calcutta Stock Exchange, Retains BSE Listing
Bijoy Hans Limited plans to voluntarily delist its equity shares from the Calcutta Stock Exchange (CSE) while maintaining its listing on BSE Limited. The decision was approved by the Board of Directors on September 26, 2025. The delisting process will follow SEBI regulations and does not require an exit opportunity for shareholders. The company will continue to trade on BSE, ensuring uninterrupted trading access for investors.
 no imag found
09Sept 25
Bijoy Hans Limited Secures BSE Trading Approval for 4.5 Crore Preferential Equity Shares
Bijoy Hans Limited has received trading approval from BSE for 45,00,000 equity shares issued on a preferential basis to promoters. The shares, priced at Rs. 12.50 each (Rs. 10 face value + Rs. 2.50 premium), will be listed and tradable from September 10, 2025. The approval, granted on September 9, 2025, complies with SEBI regulations. Guinea Agrawal, Company Secretary & Compliance Officer, confirmed the approval, which is expected to enhance stock liquidity.
 no imag found
26Aug 25
Bijoy Hans Limited Secures BSE Approval for 45 Lakh Equity Shares Preferential Issue
Bijoy Hans Limited has received approval from BSE Limited for listing 45 lakh equity shares issued on a preferential basis to promoters. The approval, granted on August 22, 2025, is for shares with a face value of Rs. 10.00, issued at a premium of Rs. 2.50 per share, totaling Rs. 12.50 per share. The total value of this equity expansion amounts to Rs. 56.25 crore. The shares bear distinctive numbers from 3000022 to 7500021. This move complies with SEBI regulations and could potentially strengthen the promoter's stake in the company.
 no imag found
11Aug 25
Bijoy Hans Limited Reports Share Transactions and Capital Increase
Bijoy Hans Limited, listed on BSE and Calcutta Stock Exchange, disclosed multiple share transactions and a significant equity capital increase. Three individuals sold a total of 38,200 shares (0.51%) to Kaushal Uttam Shah, a company promoter, through off-market transactions. Simultaneously, the company increased its equity share capital by 150%, from Rs. 3,00,00,210 to Rs. 7,50,00,210, expanding the number of shares from 30,00,021 to 75,00,021.
 no imag found
22Jul 25
Bijoy Hans Limited Set for Major Management Overhaul Following Successful Open Offer
Bijoy Hans Limited (BSE: 524723) has scheduled a board meeting for July 28, 2025, to address significant corporate changes post-open offer completion. The meeting will focus on management restructuring, including new Board of Directors composition. Key agenda items include reviewing Q2 2025 financial results, appointing new directors, reconstituting committees, and potentially re-designating Mr. Kaushal Uttam Shah as Managing Director and Chairman. The company has implemented a trading window closure from June 1 to July 30, 2025, for insiders.
 no imag found
17Jul 25
Bijoy Hans Receives SEBI Warning for Delayed Fee Payment in Open Offer Process
Bijoy Hans Limited received an administrative warning from SEBI for a 28-day delay in paying fees under the Substantial Acquisition of Shares and Takeovers (SAST) Regulations. The company filed a Draft Letter of Offer on January 3, 2025, but paid the required fees on January 31, 2025, violating Regulation 16(1). SEBI advised the company to be more careful in the future, warning of potential enforcement action for repeated violations. Bijoy Hans acknowledged the issue and committed to improving compliance measures.
 no imag found
Arvaya Healthcare
114.55
+2.20
(+1.96%)
1 Year Returns:+351.87%
Industry Peers
Redington
350.55
(+0.70%)
MMTC
65.38
(-1.34%)
MSTC
701.45
(+1.31%)
Ravindra Energy
167.63
(+0.55%)
BN Agrochem
239.95
(+1.05%)
Creative Newtech
1,247.70
(-0.04%)
TCC Concept
251.70
(-0.45%)
The Yamuna Syndicate
29,865.00
(+2.63%)